| Mr Shane Merchant, PA-C | |
|
410 W 16th Ave, Tyndall, SD 57066-2318 | |
| (605) 589-2188 | |
| (605) 589-4603 |
| Full Name | Mr Shane Merchant |
|---|---|
| Gender | Male |
| Speciality | Physician Assistant |
| Experience | 11 Years |
| Location | 410 W 16th Ave, Tyndall, South Dakota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689001166 | NPI | - | NPPES |
| 2007146 | Medicaid | SD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | 0887 (South Dakota) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Michael's Hospital - Cah | Tyndall, SD | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Michael's Hospital, Inc. | 2668380262 | 8 |
News Archive
Perhaps surprisingly, the number of copies of the carcinogenic human papillomavirus type 18 (HPV18) relative to cellular DNA is not associated with the likelihood of progression to advanced precancerous lesions of the cervix, according to a study in the January 27 online issue of the Journal of the National Cancer Institute.
Iron overload is a common and serious problem in thalassemic major patients. As iron accumulation is toxic in the body's tissues, accurate estimation of iron stores is of great importance in these patients to prevent iron overload by an appropriate iron chelating therapy.
On Thursday 7 October, Europe's top regions in healthcare technology will launch the Health-TIES consortium that aims to accelerate innovation in healthcare. The consortium is backed by a three-year grant from the European Commission and is set up to strengthen the research potential of European regions through research-driven clusters of universities, research centres, enterprises and regional authorities.
Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.
U.S. Marshals, acting at the request of the Food and Drug Administration, have seized Other-Sonic Generic Ultrasound Transmission Gel located at Pharmaceutical Innovations Inc. in Newark, N.J., after an FDA analysis found that product samples contained dangerous bacteria. The seizure included all lots of the gel product manufactured between June 2011 and December 2011.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Shane Merchant, PA-C 410 W 16th Ave, Tyndall, SD 57066-2318 Ph: (605) 589-2188 | Mr Shane Merchant, PA-C 410 W 16th Ave, Tyndall, SD 57066-2318 Ph: (605) 589-2188 |
News Archive
Perhaps surprisingly, the number of copies of the carcinogenic human papillomavirus type 18 (HPV18) relative to cellular DNA is not associated with the likelihood of progression to advanced precancerous lesions of the cervix, according to a study in the January 27 online issue of the Journal of the National Cancer Institute.
Iron overload is a common and serious problem in thalassemic major patients. As iron accumulation is toxic in the body's tissues, accurate estimation of iron stores is of great importance in these patients to prevent iron overload by an appropriate iron chelating therapy.
On Thursday 7 October, Europe's top regions in healthcare technology will launch the Health-TIES consortium that aims to accelerate innovation in healthcare. The consortium is backed by a three-year grant from the European Commission and is set up to strengthen the research potential of European regions through research-driven clusters of universities, research centres, enterprises and regional authorities.
Telik, Inc. today announced the initiation of a Phase 2 clinical trial to evaluate oral Telintra in patients with Revlimid refractory or resistant, deletion 5q myelodysplastic syndrome.
U.S. Marshals, acting at the request of the Food and Drug Administration, have seized Other-Sonic Generic Ultrasound Transmission Gel located at Pharmaceutical Innovations Inc. in Newark, N.J., after an FDA analysis found that product samples contained dangerous bacteria. The seizure included all lots of the gel product manufactured between June 2011 and December 2011.
› Verified 7 days ago
Shannon Fanning, Physician Assistant Medicare: Medicare Enrolled Practice Location: 309 E 17th Ave, Tyndall, SD 57066 Phone: 605-933-1681 | |
Amber Evenson, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 410 W 16th Ave, Tyndall, SD 57066 Phone: 605-589-2190 Fax: 605-589-4603 | |
Angela Schnetzer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 410 W 16th Ave, Tyndall, SD 57066 Phone: 605-589-3341 Fax: 605-589-4603 | |
Scott R Ulmer, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 410 W 16th Ave, Tyndall, SD 57066 Phone: 605-589-2100 Fax: 605-589-2115 | |
Mr. Bradley E Adams, PAC Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2205 Main St, Tyndall, SD 57066 Phone: 605-464-0545 | |
Kimberly Hinz, PA-C Physician Assistant Medicare: Medicare Enrolled Practice Location: 410 W 16th Ave, Tyndall, SD 57066 Phone: 605-589-2100 Fax: 605-589-2115 |